NJ-WIPRO-LIMITED
20.3.2024 14:27:30 CET | Business Wire | Press release
Wipro (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading technology services and consulting company, today announced that Anne-Marie (“Annie”) Rowland has been appointed to the role of Capco’s Chief Executive Officer. Rowland is currently Managing Partner of Capco’s business in the United Kingdom and Ireland and a member of Capco’s Global Leadership Team. She will take on the CEO role effective April 1, 2024.
As CEO of Capco, Rowland will report to Wipro CEO and Managing Director Thierry Delaporte and will become a member of Wipro’s Executive Committee (WEC).
Lance Levy, who has led Capco as CEO for close to a decade, will take on a new role as Strategic Advisor and continue to support Capco’s strategic direction and Wipro’s overall Consulting strategy.
“Lance has provided unmatched leadership to Capco for over a decade. Under his guidance, Capco has differentiated itself as an industry-leading full-service transformation consultancy, and become a key growth pillar for Wipro,” said Delaporte. “I’m glad to announce Lance’s continued support as Strategic Advisor, helping Annie and Capco’s business through a carefully planned transition. Annie has a deep understanding of Capco, our clients, teams, and the Consulting industry. I’m proud to welcome Annie to lead Capco into the future, to its next phase of growth.”
Rowland joined Capco 14 years ago and has deep Consulting expertise in business change management, innovation, and transformation.
Since joining Capco, Rowland has played a pivotal role in the growth of Capco’s business through a series of executive roles, having served on the Capco Global Leadership Team for several years in a number of capacities, including as Global Head of Capco’s Consulting and Transformation practice, Global Client Partner for a number of large financial institutions, Executive Sponsor of Women@Capco and most recently as the Managing Partner for Capco’s UK and Ireland business. Rowland was recognized by Consulting Magazine for the Global Women Leaders in Consulting Award in 2021.
Commenting on the appointment, Lance Levy, Capco’s current Chief Executive Officer, said, “Capco is an incredibly special business, and I am honored to have led the company, and very grateful to all of those who have played such an important part in the company’s founding and growth, and especially our people, who work tirelessly in fulfilling our commitment to innovation and transformational outcomes for our clients.
“I am incredibly proud of all we have achieved together, and we have continued to raise the bar in terms of our creativity, focus on innovation, domain expertise and the solutions that we have provided to our clients. I have seen at first hand Annie’s huge contribution to the success of our business and the satisfaction of our clients, and I know under her leadership we are opening a new chapter in Capco’s growth story. I look forward to continuing to work closely with both Annie and Thierry in my new role as Strategic Advisor.”
Capco, acquired by Wipro in 2021, has been a trusted client advisor and industry player for over 25 years, evolving from a niche service provider to become the world’s largest, independent, financial services management consultancy. Capco combines deep domain expertise, a disruptive mindset, and a proven track record of delivering lasting value to solve clients’ most complex transformational challenges.
“I am delighted about the opportunity to lead Capco into the next phase of its journey,” said Annie Rowland, Capco’s incoming Chief Executive Officer. “As a long-time Capco veteran, I am committed to preserving all that makes Capco special: our client relationships, our unique and authentic culture, and our focus on innovation and creativity.
“Our clients’ needs are changing at pace as they look to meet the challenges and opportunities presented by emerging technology and evolving business landscapes. Together, Capco and Wipro are a winning combination that delivers the deep expertise, focus and scale required to ensure our clients’ future success. I am delighted to be taking the helm of such a remarkable company, and I want to thank Lance for his exceptional leadership and guidance over the years, and I know we will continue to work closely together as he moves forward in his new role.”
About Wipro
Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO) is a leading technology services and consulting company focused on building innovative solutions that address clients’ most complex digital transformation needs. Leveraging our holistic portfolio of capabilities in consulting, design, engineering, and operations, we help clients realize their boldest ambitions and build future-ready, sustainable businesses. With over 240,000 employees and business partners across 65 countries, we deliver on the promise of helping our customers, colleagues, and communities thrive in an ever-changing world. For additional information, visit us at www.wipro.com.
About Capco
Capco, a Wipro company, is a global technology and management consultancy focused on the financial services and energy industries. Capco operates at the intersection of business and technology by combining innovative thinking with unrivalled industry knowledge to fast-track digital initiatives for banking and payments, capital markets, wealth and asset management, insurance, and the energy sector. Capco’s cutting-edge ingenuity is brought to life through its award-winning Be Yourself At Work culture and diverse talent. To learn more, visit www.capco.com or follow us on LinkedIn, Instagram, Facebook, and YouTube.
Forward-Looking Statements
The forward-looking statements contained herein represent Wipro’s beliefs regarding future events, many of which are by their nature, inherently uncertain and outside Wipro’s control. Such statements include, but are not limited to, statements regarding Wipro’s growth prospects, its future financial operating results, and its plans, expectations and intentions. Wipro cautions readers that the forward-looking statements contained herein are subject to risks and uncertainties that could cause actual results to differ materially from the results anticipated by such statements. Such risks and uncertainties include, but are not limited to, risks and uncertainties regarding fluctuations in our earnings, revenue and profits, our ability to generate and manage growth, complete proposed corporate actions, intense competition in IT services, our ability to maintain our cost advantage, wage increases in India, our ability to attract and retain highly skilled professionals, time and cost overruns on fixed-price, fixed-time frame contracts, client concentration, restrictions on immigration, our ability to manage our international operations, reduced demand for technology in our key focus areas, disruptions in telecommunication networks, our ability to successfully complete and integrate potential acquisitions, liability for damages on our service contracts, the success of the companies in which we make strategic investments, withdrawal of fiscal governmental incentives, political instability, war, legal restrictions on raising capital or acquiring companies outside India, unauthorized use of our intellectual property and general economic conditions affecting our business and industry.
Additional risks that could affect our future operating results are more fully described in our filings with the United States Securities and Exchange Commission, including, but not limited to, Annual Reports on Form 20-F. These filings are available at www.sec.gov. We may, from time to time, make additional written and oral forward-looking statements, including statements contained in the company’s filings with the Securities and Exchange Commission and our reports to shareholders. We do not undertake to update any forward-looking statement that may be made from time to time by us or on our behalf and our reports to shareholders. We do not undertake to update any forward-looking statement that may be made from time to time by us or on our behalf.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240320633322/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
